Finding ways to improve immune responses in head and neck cancers
Strategies to Overcome Immune Resistance in Head and Neck Cancers
['FUNDING_P01'] · YALE UNIVERSITY · NIH-10690599
This study is looking at ways to improve immunotherapy for people with head and neck cancer, aiming to help more patients respond to treatment by figuring out why the immune system sometimes doesn't fight the cancer effectively.
Quick facts
| Phase | ['FUNDING_P01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | YALE UNIVERSITY (nih funded) |
| Locations | 1 site (NEW HAVEN, UNITED STATES) |
| Trial ID | NIH-10690599 on ClinicalTrials.gov |
What this research studies
This research focuses on head and neck squamous cell carcinoma (HNSCC), a type of cancer that has limited treatment options. The project aims to enhance the effectiveness of immunotherapy, which has shown some success but only benefits a small number of patients. Researchers will investigate the reasons behind the immune system's failure to respond to tumors and develop new strategies to overcome these barriers. By understanding both the tumor's characteristics and the immune system's suppression, the goal is to create innovative treatment combinations that can help more patients respond positively to immunotherapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with head and neck squamous cell carcinoma who have limited treatment options.
Not a fit: Patients with other types of cancers or those who do not have head and neck squamous cell carcinoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve treatment outcomes for patients with head and neck cancers by increasing the effectiveness of immunotherapy.
How similar studies have performed: Other research has shown promise in enhancing immunotherapy responses in various cancers, suggesting that this approach could lead to meaningful advancements.
Where this research is happening
NEW HAVEN, UNITED STATES
- YALE UNIVERSITY — NEW HAVEN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PAI, SARA ISABEL — YALE UNIVERSITY
- Study coordinator: PAI, SARA ISABEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.